FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

Public Hearing on MedGuide

04/09/2007

Federal Register Notice: CDER will hold a public hearing to obtain feedback on FDA's Medication Guide program, The hearing will re...

Device Reg Errors Corrected

04/09/2007

Federal Register Final rule: FDA is amending certain medical device regulations to correct typographical errors and to ensure accu...

Panel to Discuss Antimicrobials on Surgical Gear

04/09/2007

Federal Register Notice: FDA’s General Hospital and Personal Use Devices Panel will meet 5/4, from 8 a.m. to 5 p.m. at the H...

Public Hearing on MedGuide

04/09/2007

Subcommittee Meeting Canceled

04/05/2007

Federal Register Notice: The meeting of the Manufacturing Subcommittee of the Advisory Committee for Pharmaceutical Science and Cl...

Panel Meeting Canceled

04/05/2007

Federal Register Notice: FDA’s Advisory Committee for Pharmaceutical Science and Clinical Pharmacology scheduled for 5/1-2 i...

Review Period Set for Ranexa

04/02/2007

Federal Register Notice: FDA has determined the regulatory review period for Roche Palo Alto, L.L.C.’s Ranexa, is 6,770 days...

Public Hearing on Electronic Prescribing Info

04/02/2007

Federal Register Notice: FDA will hold a public hearing 4/27 to solicit views and information from interested parties on electroni...

Orange County Education Conference Planned

04/02/2007

Federal Register Notice: FDA will hold the 10th Annual Educational Conference 6/11-12 co-sponsored with the Orange County Regulato...

Review Period Set for Chiron’s Kepivance

04/02/2007

Federal Register Notice: FDA has determined the regulatory review period for Chiron Corp.’s Kepivance (palifermin) is 3,303 ...